BioAtla, Inc. (BCAB) vs VivoSim Labs, Inc. (VIVS)
- BioAtla, Inc. BCAB 1.36 +4.62%
- VivoSim Labs, Inc. VIVS 0.16 −5.88%
BioAtla, Inc. and VivoSim Labs, Inc. are both Biotechnology companies. BioAtla, Inc. and VivoSim Labs, Inc. are of similar size ($2.9M and $2.8M). BioAtla, Inc. grew revenue faster over the last twelve months: 574.7% against −21.1%. BioAtla, Inc. has the higher net margin (−177.2% vs −11,016.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, BioAtla, Inc. leads on 10 and VivoSim Labs, Inc. on 5.
Valuation
Profitability
| Metric | BCAB | VIVS | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.44% | 100.00% | 65.16% |
| Operating margin | (180.99%) | (10,116.96%) | 0.00% |
| Net margin | (177.21%) | (11,016.07%) | 0.00% |
| Free cash flow margin | (132.29%) | (1,014.29%) | 0.00% |
| Return on equity | 118.74% | (343.10%) | (56.36%) |
| Return on assets | (171.72%) | (155.93%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack